SHH · 603259.SS
WuXi AppTec Co., Ltd.
CN¥143.36+CN¥0.47 (+0.33%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.42% below the high.
Loading market information…
SHZ · 002821.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:05 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Asymchem Laboratories (Tianjin) Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Asymchem Laboratories (Tianjin) Co., Ltd.’s forward annual dividend is CN¥1.30 per share, paid annual. The forward yield is 0.98% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Asymchem Laboratories (Tianjin) Co., Ltd.’s next earnings report is currently expected on Apr 1, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Asymchem Laboratories (Tianjin) Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | Apr 23, 2025 | CN¥0.89 | CN¥1.54B |
|---|
| Q4 2024 | Mar 28, 2025 | CN¥0.68+183.33% vs estimate | CN¥1.66B-3.63% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥143.36+CN¥0.47 (+0.33%)
WuXi AppTec Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 17.42% below the high.
CN¥48.79+CN¥0.17 (+0.35%)
Jiangsu Hengrui Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 25.88% below the high.
HK$51.35+HK$0.70 (+1.38%)
Jiangsu Hengrui Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 36.57% below the high.
CN¥40.79+CN¥0.79 (+1.98%)
Pharmaron Beijing Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 23.86% below the high.
CN¥19.29-CN¥0.21 (-1.08%)
Apeloa Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.32% below the high.
CN¥91.00+CN¥7.88 (+9.48%)
Shanghai Haoyuan Chemexpress Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.24% below the high.
CN¥43.98+CN¥1.28 (+3.0%)
PharmaBlock Sciences (Nanjing), Inc.’s quoted price sits in the lower half of its reported 52-week range, 23.58% below the high.
CN¥20.07+CN¥0.02 (+0.1%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.81% below the high.
